Effect of formulation variables on in vitro drug release and micromeritic properties of modified release ibuprofen microspheres
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 16 (4) , 475-487
- https://doi.org/10.1080/026520499288924
Abstract
Modified release microspheres of the non-steroidal anti-inflammatory drug, ibuprofen, were formulated and prepared using the emulsion solvent diffusion technique. The contribution of various dispersed phase and continuous phase formulation factors on in vitro drug release and micromeritic characteristics of microspheres was examined. The results demonstrated that the use of Eudragit RS 100 and Eudragit RL 100 as embedding polymers modified the drug release properties as a function of polymer type and concentration. Eudragit RS 100 retarded ibuprofen release from the microspheres to a greater extent than Eudragit RL 100. The drug/polymer concentration of the dispersed phase influenced the particle size and drug release properties of the formed microspheres. It was found that the presence of emulsifier was essential for microsphere formation. Increasing the concentration of emulsifier, sucrose fatty acid ester F-70, decreased the particle size which contributed to increased drug release properties. Scanning electron microscopy revealed profound distortion in both the shape and surface morphology of the microspheres with the use of magnesium stearate as added emulsifier. The application of an additional Eudragit RS 100 coat onto formed microspheres using fluid bed technology was successful and modulated the drug release properties of the coated microspheres.Keywords
This publication has 9 references indexed in Scilit:
- An investigation of the effects of some process variables on the microencapsulation of propranolol hydrochloride by the solvent evaporation methodInternational Journal of Pharmaceutics, 1995
- The Development of an Oral Controlled Release Pellets Formulation of Diethylpropion HydrochlorideDrug Development and Industrial Pharmacy, 1994
- Microencapsulation of benzalkonium chlorideInternational Journal of Pharmaceutics, 1992
- Encapsulation of 5-aminosalicylic acid into Eudragit RS microspheres and modulation of their release characteristics by use of surfactantsJournal of Controlled Release, 1991
- Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Polyacrylate (Eudragit Retard) Microspheres for Oral Controlled Release of Nifedipine. I. Formulation Design and Process OptimizationDrug Development and Industrial Pharmacy, 1990
- Preparation and evaluation of controlled release furosemide microspheres by spherical crystallizationInternational Journal of Pharmaceutics, 1989
- Preparation of Controlled-Release Microspheres of Ibuprofen With Acrylic Polymers by a Novel Quasi-Emulsion Solvent Diffusion MethodJournal of Pharmaceutical Sciences, 1989
- IbuprofenAnnals of Internal Medicine, 1979